Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01065961Phase 2Unknown
Phase 2, randomised, double-blind trial of dexamethasone in dysphagia and Airflow Limitation (2 arms), sponsored by Albany Medical College. Primary endpoint: Good bony fusion at 1 year. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01065961.